Company news
Rhythm Biosciences Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Rhythm Successfully Validates Two Adjunct Biomarkers
September 15, 2020
Revised CEO Contract and LTIP for all employees - amended
September 14, 2020
Revised CEO Contract and LTIP initiated for all employees
September 13, 2020
Addtl Clinical Trial Site Signed - First Patient Recruited
September 9, 2020
Non-renounceable rights issue Offer
July 31, 2020
Placement & Rights Offer to raise approximately $6 million
July 22, 2020
COVID-19 Update
April 8, 2020
Successful ISO13485 Surveillance Audit
April 5, 2020
Rhythm Successfully Validates Key Biomarker
April 1, 2020
Rhythm Biosciences Granted China Patent
November 3, 2019
ColoSTAT - Test Development Update
September 19, 2019
Appendix 4C
July 25, 2019
Rhythm signs Alfred Hospital for ColoSTAT clinical trial
June 26, 2019
Monash Health signed with first patients recruited
June 17, 2019
Rhythm Biosciences receives ISO certification
May 21, 2019
Rhythm recruits first patient in ColoSTAT clinical trial
March 17, 2019
RHY Signs first ColoSTAT site for Clinical Trial - Study 7
February 19, 2019
Corporate Presentation
February 10, 2019
Rhythm Completes Reagent Development Program
December 4, 2018
Appointment of CEO - Senior Management Changes
November 27, 2018
AGM Presentation
November 25, 2018
Final Antibody Selection Complete
October 2, 2018
Rhythm completes cloning of key reagent ahead of schedule
June 20, 2018
Rhythm Granted Biomarker Patent in Europe
May 16, 2018
RHYs Four Antibodies Pass all Three Key Screening Tests
May 14, 2018
Reagent Development Update
April 23, 2018
Appendix 4D - Half Yearly Report
February 28, 2018
Rhythm reports reagent development update
February 7, 2018
Quarterly report and Appendix 4C
January 30, 2018
CSIRO and Rhythm Commence Development of Key Reagents
January 24, 2018
CSIRO to assist Rhythm Biosciences develop key reagents
January 8, 2018
Admission to Official List
December 6, 2017
Decks
The 5 newest of 46 decks. Every deck is listed under its year.
- Q1 FY27 Earnings Presentation
Earnings · 18 slides · Nov 4, 2026
- 20th Bioshares Biotech Summit 2026
Conference · 15 slides · Aug 6, 2026
- Accreditation Matters Conference 2026
Conference · 15 slides · Jul 7, 2026
- Investor Presentation (June 2026)
Investor deck · 19 slides · Jun 4, 2026
- Corporate Update (May 2026)
Corporate update · 9 slides · May 13, 2026